Texas, N. Carolina, Ohio, Pennsylvania — where pharma manufacturing investments have surged

Pharma’s U.S. manufacturing investments skyrocketed in 2025, with major companies promising more than $370 billion over the next five years, according to a market trend report from DPR Construction, which counts pharma giants like Eli Lilly, Pfizer, Johnson & Johnson, Merck & Co., Novartis and Roche among its clients